Celeste Yu

3.1k total citations
27 papers, 271 citations indexed

About

Celeste Yu is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Celeste Yu has authored 27 papers receiving a total of 271 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cancer Research, 12 papers in Oncology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Celeste Yu's work include Cancer Genomics and Diagnostics (17 papers), Genetic factors in colorectal cancer (10 papers) and Colorectal Cancer Treatments and Studies (7 papers). Celeste Yu is often cited by papers focused on Cancer Genomics and Diagnostics (17 papers), Genetic factors in colorectal cancer (10 papers) and Colorectal Cancer Treatments and Studies (7 papers). Celeste Yu collaborates with scholars based in Canada, United States and Spain. Celeste Yu's co-authors include Oksana Shynlova, John Challis, Xuesen Dong, Stephen J. Lye, Paul S. Rennie, Philippe L. Bédard, Lillian L. Siu, Suzanne Kamel‐Reid, Neesha C. Dhani and Ming‐Sound Tsao and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Celeste Yu

25 papers receiving 266 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Celeste Yu Canada	8	94	88	73	63	55	27	271
Simona Pigozzi Italy	9	101 1.1×	51 0.6×	121 1.7×	51 0.8×	61 1.1×	24	320
Andrew Fischer United States	7	133 1.4×	107 1.2×	71 1.0×	47 0.7×	75 1.4×	10	346
Songchang Chen China	12	135 1.4×	50 0.6×	34 0.5×	34 0.5×	58 1.1×	51	356
Qian‐Ying Zhu China	8	55 0.6×	35 0.4×	90 1.2×	30 0.5×	30 0.5×	15	211
Jacqueline McDermott United Kingdom	11	109 1.2×	80 0.9×	143 2.0×	29 0.5×	114 2.1×	20	370
Shohreh Ghazali United Kingdom	5	175 1.9×	144 1.6×	66 0.9×	43 0.7×	21 0.4×	5	305
Lise Portelance Canada	10	97 1.0×	42 0.5×	86 1.2×	26 0.4×	27 0.5×	16	254
Kevin Bushell Canada	6	87 0.9×	97 1.1×	49 0.7×	54 0.9×	26 0.5×	9	209
Carolina Ferraz Brazil	12	98 1.0×	88 1.0×	35 0.5×	21 0.3×	17 0.3×	25	452
Mackenzie Coatham Canada	8	266 2.8×	80 0.9×	51 0.7×	72 1.1×	54 1.0×	8	457

Countries citing papers authored by Celeste Yu

Since Specialization

Citations

This map shows the geographic impact of Celeste Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Celeste Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Celeste Yu more than expected).

Fields of papers citing papers by Celeste Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Celeste Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Celeste Yu. The network helps show where Celeste Yu may publish in the future.

Co-authorship network of co-authors of Celeste Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Celeste Yu. A scholar is included among the top collaborators of Celeste Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Celeste Yu. Celeste Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Elliott, Mitchell J., Jesús Fuentes‐Antrás, Eitan Amir, et al.. (2025). Comprehensive tumor-agnostic evaluation of genomic and epigenomic-based approaches for the identification of circulating tumor DNA in early-stage breast cancer. ESMO Open. 10(6). 105286–105286. 1 indexed citations

Elliott, Mitchell J., Christodoulos Pipinikas, Jesús Fuentes‐Antrás, et al.. (2025). Longitudinal evaluation of circulating tumor DNA in patients undergoing neoadjuvant therapy for early breast cancer using a tumor-informed assay. Nature Communications. 16(1). 1837–1837. 5 indexed citations

Saleh, Ramy, et al.. (2024). Clinical Utility of Tumor Next-Generation Sequencing Panel Testing to Inform Treatment Decisions for Patients With Advanced Solid Tumors in a Tertiary Care Center. JCO Precision Oncology. 8(8). e2400092–e2400092. 2 indexed citations

Nguyen, Paul, Philippe L. Bédard, Kelvin Chan, et al.. (2023). Impact on costs and outcomes of multi-gene panel testing for advanced solid malignancies: A cost consequence analysis using linked administrative data.. Journal of Clinical Oncology. 41(16_suppl). 6650–6650. 2 indexed citations

Elliott, Mitchell J., Jesús Fuentes‐Antrás, Zachary Veitch, et al.. (2023). 310P Longitudinal evaluation of circulating tumour DNA in early breast cancer using a plasma-only methylation-based assay. Annals of Oncology. 34. S308–S308. 4 indexed citations

Saleh, Ramy, et al.. (2022). Clinical utility of tumor next-generational sequencing (NGS) panel testing to inform treatment decisions for patients with advanced solid tumors.. Journal of Clinical Oncology. 40(16_suppl). 3119–3119. 1 indexed citations

Lavery, Jessica A., Samantha Brown, Gregory J. Riely, et al.. (2021). Pan-cancer evaluation of homologous repair deficiency somatic mutations and response to first-line anti-neoplastic therapy.. Journal of Clinical Oncology. 39(15_suppl). 10535–10535. 1 indexed citations

Xia, Daniel, Alberto J. León, Michael Cabanero, et al.. (2020). Minimalist approaches to cancer tissue-of-origin classification by DNA methylation. Modern Pathology. 33(10). 1874–1888. 22 indexed citations

Stutheit-Zhao, Eric Y., Jonathon Torchia, Dax Torti, et al.. (2020). Exomes and transcriptomes to reveal actionable findings in patients with negative-targeted panel sequencing.. Journal of Clinical Oncology. 38(15_suppl). 3562–3562. 1 indexed citations

10.

Saleh, Ramy, Philippe L. Bédard, Paul Nguyen, et al.. (2020). An evaluation of administrative data linkage for measurement of real-world outcomes of large clinical panel sequencing for advanced solid tumors.. Journal of Clinical Oncology. 38(29_suppl). 283–283.

11.

Spence, Tara, Natalie Stickle, Celeste Yu, et al.. (2019). Inter-Laboratory Proficiency Testing Scheme for Tumour Next-Generation Sequencing in Ontario: A Pilot Study. Current Oncology. 26(6). 717–732. 2 indexed citations

12.

Han, Kathy, Jinfeng Zou, Celeste Yu, et al.. (2019). Viral Genome Sequencing for Ultrasensitive Detection of Circulating Tumor DNA. International Journal of Radiation Oncology*Biology*Physics. 105(1). S177–S177. 3 indexed citations

13.

Spreafico, Anna, Amit M. Oza, Blaise Clarke, et al.. (2017). Genotype-matched treatment for patients with advanced type I epithelial ovarian cancer (EOC). Gynecologic Oncology. 144(2). 250–255. 21 indexed citations

14.

Pezo, Rossanna C., Tom Wei‐Wu Chen, Hal K. Berman, et al.. (2017). Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer. Breast Cancer Research and Treatment. 168(1). 159–168. 22 indexed citations

15.

Chiu, Joanne, Monika K. Krzyzanowska, Stefano Serra, et al.. (2017). Molecular Profiling of Patients With Advanced Colorectal Cancer: Princess Margaret Cancer Centre Experience. Clinical Colorectal Cancer. 17(1). 73–79. 21 indexed citations

16.

Chiu, Joanne, Philippe L. Bédard, Michael H. A. Roehrl, et al.. (2014). Molecular profiling of patients (pts) with advanced colorectal cancer (CRC): Princess Margaret Cancer Centre experience.. Journal of Clinical Oncology. 32(3_suppl). 459–459. 2 indexed citations

17.

Spreafico, Anna, Amit M. Oza, Blaise Clarke, et al.. (2014). Genotype matched treatment for patients with advanced type I epithelial ovarian cancer (EOC).. Journal of Clinical Oncology. 32(15_suppl). 5506–5506. 4 indexed citations

18.

Bédard, Philippe L., Amit M. Oza, Ming‐Sound Tsao, et al.. (2013). Princess Margaret Cancer Centre (PMCC) Integrated Molecular Profiling in Advanced Cancers Trial (IMPACT) using genotyping and targeted next-generation sequencing (NGS).. Journal of Clinical Oncology. 31(15_suppl). 11002–11002. 20 indexed citations

19.

Dong, Xuesen, Celeste Yu, Oksana Shynlova, et al.. (2009). p54nrb Is a Transcriptional Corepressor of the Progesterone Receptor that Modulates Transcription of the Labor-Associated Gene, Connexin 43 (Gja1). Molecular Endocrinology. 23(8). 1147–1160. 72 indexed citations

20.

Rahbar, Ramtin, Thomas T. Murooka, Carole L. Galligan, et al.. (2006). Vaccinia Virus Activation of CCR5 Invokes Tyrosine Phosphorylation Signaling Events That Support Virus Replication. Journal of Virology. 80(14). 7245–7259. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact